Clinical trial
An Evaluation of Etanercept in the Treatment of Subjects With Psoriasis
NCT00111111 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00111111 |
|---|---|
| Title | An Evaluation of Etanercept in the Treatment of Subjects With Psoriasis |
| Official title | A Multicenter, Open-Label, Prospective Study to Evaluate the Effectiveness and Safety of Etanercept in the Treatment of Subjects With Psoriasis |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Psoriasis |
| Intervention type | Drug |
| Interventions | Etanercept |
| First posted | May 18, 2005 |
| Last update posted | May 29, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: